p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization

Makoto Akashi, Yoshiaki OSAWA, H. Phillip KOEFFLER, Misao Hachiya

Biochemical Journal · 1999 · 18 citations · 2 references

DOIFull text

Open access

Concepts

Abstract

p21 WAF" inhibits cyclin-cyclin-dependent kinase (Cdk) complexes, causing cell cycle arrest. p21 WAF" contains p53-binding sites in its promoter and expression of p21 WAF" is induced by functional p53. In the present work, we have studied the role of protein kinase C (PKC) in the induction of p21 WAF" and show that induction of p21 WAF" expression can occur by activation of PKC in cells having no p53. Human ovarian carcinoma cells, SKOV-3, lack p53 protein and PMA, a potent activator of PKC, did not induce p53. PMA increased the expression of p21 WAF" mRNA both in these cells and in other cells which do not contain p53 (THP-1 and U937). Treatment of human embryonic fibroblasts, WI38, with PMA also induced the accumulation of p21 WAF" without affecting p53 levels. However, PMA did not increase levels of p21 WAF" mRNA in cells where either the PKC or the mitogen-activated protein kinase pathway was blocked. Furthermore, treatment of cells with various phorbol ester Abbreviations used : PKC, protein kinase C ; Cdk, cyclin-dependent kinase ; MAPK, mitogen-activated protein kinase ; G3PDH, glyceraldehyde-3phosphate dehydrogenase ; MEK, MAPK kinase ; PDD, phorbol 12,13-didecanoate ; 4-PDD, 4-phorbol 12,13-didecanoate ; PDB, phorbol 12,13dibutyrate ; 3hUTR, 3h-untranslated region.

References

2